- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Jerini AG
Headquarters: Berlin, Germany
Website: N/A
Year Founded: 1994
Status: Acquired
BioCentury | Dec 10, 2022
Product Development
Dec. 9 Quick Takes: Trio of biotechs parlays data into follow-ons
Plus: Erasca adds pan-RAF inhibitor from Novartis, and updates from UCB, Ambrx, Pharvaris and more
BioCentury | Apr 24, 2021
Product Development
Affimed’s persistence with innate cell engagers finally gaining traction with investors
Affimed’s 15-plus year journey to investor buy-in for its innate cell engagers
BioCentury | Sep 10, 2019
Financial News
Pharvaris raises $66M series B for clinical development of oral HAE therapy
BioCentury | May 31, 2018
Emerging Company Profile
Oral route for HAE
Why Pharvaris believes its oral compound can stand out in the crowded HAE field
BioCentury | Jan 18, 2016
Strategy
Shire's serial story
How Baxalta deal will help Shire evaluate new M&A opportunities
BioCentury | Apr 1, 2013
Strategy
Shire sees opportunity
Incoming Shire CEO outlines ophthalmics strategy after SARcode, Premacure deals
Items per page:
1 - 10 of 115